Form 4: Roivant Sciences Director Files Form 4 for Pre-Scheduled Future Share Distribution and RSU Vesting

Roivant Sciences Ltd. Director Keith S. Manchester filed a Form 4 detailing an upcoming pre-scheduled in-kind share distribution from QVT entities and the future vesting of his restricted stock units.

Summary

• Keith S. Manchester, a Director of Roivant Sciences Ltd. (ROIV), filed a Form 4 detailing future changes in his beneficial ownership, specifically transactions scheduled for June 25, 2025.
• The filing indicates that on June 25, 2025, several QVT entities (QVT Roiv Hldgs Onshore Ltd., QVT P&E Roiv Hldgs Ltd., QVT Deferred Compensation Holdings Ltd, and QVT Financial Investment Cayman Ltd.) are scheduled to make an in-kind distribution of Common Shares on a pro rata basis, for no consideration. This transaction is made pursuant to a Rule 10b5-1 plan.
• As a result of this distribution, Mr. Manchester is expected to directly acquire 1,933,879 Common Shares. This change in ownership form is exempted under Rule 16a-9 and/or Rule 16a-13.
• Mr. Manchester's direct holdings also include Restricted Stock Units (RSUs) granted pursuant to the Company's 2021 Equity Incentive Plan and Non-Employee Director Compensation Policy.
• One RSU award vested on September 12, 2024.
• Another RSU award is scheduled to vest 100% on September 10, 2025, contingent on his continuous service.
• Mr. Manchester disclaims beneficial ownership of shares held indirectly by the QVT Entities, except to the extent of his pecuniary interest, as he does not have voting or investment control over these entities.

Sentiment

Score: 6

Explanation: The filing is a routine disclosure of insider share ownership changes and RSU vesting. It's neutral in terms of company performance but shows continued director equity alignment and compensation.

Positives

• Director Keith Manchester's direct beneficial ownership is set to increase by 1,933,879 shares due to a pre-scheduled in-kind distribution and RSU vesting, aligning his interests further with shareholders.
• The vesting of Restricted Stock Units (RSUs) on September 12, 2024, and a future vesting on September 10, 2025, indicates ongoing compensation and retention of a key director.
• The transaction is made pursuant to a Rule 10b5-1 plan, indicating a pre-arranged, transparent transaction.

Risks

• The future vesting of RSUs on September 10, 2025, is subject to Keith Manchester's continuous service, meaning the shares would not vest if his service terminates before that date.

Future Outlook

The document indicates future vesting of Restricted Stock Units (RSUs) for Director Keith S. Manchester on September 10, 2025, contingent on his continuous service. The in-kind distribution of shares from QVT entities is also a pre-scheduled future event.

Management Comments

• "The reporting person is a shareholder of each of QVT Roiv, QVT DCH, QVT P&E and QVT QVT FIC (the 'QVT Entities') but does not have any voting or investment control over the QVT Entities."
• "The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose."

Industry Context

This Form 4 filing is a routine disclosure of changes in beneficial ownership by an insider. It does not provide information on broader industry trends or competitive landscape. It reflects an individual director's equity holdings and compensation structure within Roivant Sciences Ltd.

Corporate Governance

Related Party Transactions

• The in-kind distribution involves QVT entities, where Keith S. Manchester is a shareholder, though he disclaims voting or investment control over these entities. This constitutes a related party transaction in the context of his beneficial ownership.

Stakeholder Impact

• Shareholders: The increase in direct beneficial ownership by a director aligns his interests with shareholders. The disclaimer regarding indirect ownership from QVT entities clarifies the nature of his control.

Next Steps

• Continued service of Keith S. Manchester through September 10, 2025, for the full vesting of his remaining RSU award.
• Winding down of QVT Roiv Hldgs Offshore Ltd., facilitated by the in-kind distribution.

Key Dates

Recommendation

Keywords

Roivant Sciences, ROIV, SEC Form 4, Keith Manchester, Director, Beneficial Ownership, Share Distribution, Restricted Stock Units, RSU, Insider Transaction, Equity Incentive Plan, Corporate Governance, Rule 10b5-1